| dc.date.accessioned | 2019-03-27T15:58:41Z | |
| dc.date.accessioned | 2022-10-18T22:14:15Z | |
| dc.date.available | 2019-03-27T15:58:41Z | |
| dc.date.available | 2022-10-18T22:14:15Z | |
| dc.date.created | 2019-03-27T15:58:41Z | |
| dc.date.issued | 2016 | |
| dc.identifier | http://hdl.handle.net/10533/234535 | |
| dc.identifier | 1140553 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/4465892 | |
| dc.description.abstract | Objective: Our
aim
was
to
study
the
gene
expression
paNern
of
monocyte-‐derived
tolerogenic
DCs
(tolDCs)
obtained
through
modulaUon
with
dexamethasone
and
monophosphoryl
lipid
A
(MPLA-‐tDCs)
in
order
to
idenUfy
molecular
regulators
and
pathways
that
det | |
| dc.language | eng | |
| dc.relation | 10° | |
| dc.relation | info:eu-repo/grantAgreement/Fondecyt/1140553 | |
| dc.relation | International Congress on Autoimmunity | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.title | Transcriptional programs of monocyte-derived tolerogenic dendritic cells from rheumatoid
arthritis patients and healthy subjects obtained by modulation with dexamethasone and monophosphoryl lipid A. | |
| dc.type | Ponencia | |
